ARCHER: Dacomitinib (D; PF-00299804) versus erlotinib (E) for advanced (adv) non-small cell lung cancer (NSCLC)—A randomized double-blind phase III study.
Michael J. Boyer
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer; Roche
Research Funding - Pfizer
Other Remuneration - Roche
Pasi A. Janne
Consultant or Advisory Role - Abbott Laboratories; AstraZeneca; Boehringer Ingelheim; FORMA Therapeutics; Genentech; Pfizer (U); Quintiles/TMD; Roche
Stock Ownership - GATEKEEPER Pharmaceuticals
Other Remuneration - LabCorp
Tony Mok
Employment or Leadership Position - Chinese University of Hong Kong
Consultant or Advisory Role - AstraZeneca; AVEO; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Lilly; Merck Serono; Pfizer; Roche; Taiho Pharmaceutical
Honoraria - AstraZeneca; AVEO; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Lilly; Merck Serono; Pfizer; Roche; Taiho Pharmaceutical
Research Funding - AstraZeneca
Kenneth John O'Byrne
Consultant or Advisory Role - Pfizer; Roche
Honoraria - Pfizer; Roche
Research Funding - Pfizer; Roche
Other Remuneration - Pfizer; Roche
Luis G. Paz-Ares
Consultant or Advisory Role - Bayer; Lilly; Pfizer; Roche
Honoraria - Bayer; Lilly; Pfizer; Roche
Suresh S. Ramalingam
Consultant or Advisory Role - Genentech; Pfizer
Jane Q Liang
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Ian Taylor
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Alicyn Campbell
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer (I); Pfizer
Joseph P. O'Connell
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Stephen P. Letrent
Employment or Leadership Position - Pfizer; Pfizer (I)
Stock Ownership - Pfizer (B)
Vladan Antic
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer